Back

Physiological cerebrospinal fluid like medium reveals autophagy dependency of leukaemia in the central nervous system

Himonas, K.; Manoharan, A.; Roy, K.; Rattigan, K. M.; Ianniciello, A.; Zarou, M.; Sarnello, D.; Martin, L.; Shoemaker, R.; Sumpton, D.; Tardito, S.; Halsey, C.; Helgason, V.

2026-03-11 cancer biology
10.64898/2026.03.09.709824 bioRxiv
Show abstract

Nutrient availability is a critical environmental factor that influences the metabolism and adaptability of cancer cells, including acute lymphoblastic leukaemia (ALL) cells, prone to relapse in the central nervous system (CNS). Currently available cell culture media contain supraphysiological nutrient levels and do not represent the restricted metabolic environment of CNS-ALL which resides in the leptomeninges surrounded by cerebrospinal fluid (CSF). Therefore, we formulated a novel physiological CSF-like cell culture medium (CSFmax) that recapitulates the unique metabolite composition of the CSF. Through in vitro and in vivo metabolic and functional studies, we demonstrate that ALL cells cultured in CSFmax rewire their metabolism, closely mimicking the metabolic phenotype of CNS-ALL, including their metabolic activity and redox state. Utilising CSFmax, in comparison to conventional nutrient-rich culture media, we identified an essential role for autophagy in ALL adaptation to the CNS niche. This was evident by increased autophagic activity and selective sensitisation of ALL cells to pharmacological inhibition of autophagy and genetic knockout of Unc-51 Like Autophagy Activating Kinase 1 (ULK1) or autophagy related 7 (ATG7). Importantly, using a robust preclinical in vivo model, mice xenografted with ULK1 and ATG7 deficient ALL cells exhibited reduced CNS disease burden when compared to mice xenografted with control cells. Overall, our findings provide strong evidence that physiological CSFmax is superior to current in vitro culture systems in recapitulating the metabolic signature of CNS resident ALL cells. By exploiting this system, we revealed for the first time autophagy as a targetable therapeutic vulnerability in CNS-ALL. Key PointsO_LICulturing ALL cells in bespoke CSF-like medium (CSFmax) recapitulates the metabolic adaptation of ALL cells in the CNS niche C_LIO_LIAutophagy is critical for metabolic adaptation and survival of CNS resident ALL cells C_LI

Matching journals

The top 17 journals account for 50% of the predicted probability mass.

1
EMBO Molecular Medicine
85 papers in training set
Top 0.1%
6.9%
2
Blood Advances
54 papers in training set
Top 0.2%
6.5%
3
Cancer Research Communications
46 papers in training set
Top 0.1%
4.4%
4
Leukemia
39 papers in training set
Top 0.3%
4.0%
5
Scientific Reports
3102 papers in training set
Top 35%
3.7%
6
Cell Reports Methods
141 papers in training set
Top 1%
3.1%
7
Cell Reports
1338 papers in training set
Top 20%
2.1%
8
Cancers
200 papers in training set
Top 2%
2.1%
9
eLife
5422 papers in training set
Top 35%
2.1%
10
Neuro-Oncology
30 papers in training set
Top 0.3%
2.1%
11
Biomedicine & Pharmacotherapy
43 papers in training set
Top 0.3%
2.1%
12
Molecular Oncology
50 papers in training set
Top 0.2%
2.1%
13
Nature Communications
4913 papers in training set
Top 48%
1.9%
14
iScience
1063 papers in training set
Top 13%
1.8%
15
Haematologica
24 papers in training set
Top 0.2%
1.8%
16
Cell Reports Medicine
140 papers in training set
Top 3%
1.7%
17
JCI Insight
241 papers in training set
Top 3%
1.7%
50% of probability mass above
18
British Journal of Haematology
15 papers in training set
Top 0.3%
1.5%
19
Communications Biology
886 papers in training set
Top 12%
1.4%
20
PLOS ONE
4510 papers in training set
Top 58%
1.4%
21
Frontiers in Oncology
95 papers in training set
Top 2%
1.4%
22
Cells
232 papers in training set
Top 3%
1.4%
23
Oncogenesis
12 papers in training set
Top 0.1%
1.2%
24
Cell Communication and Signaling
35 papers in training set
Top 0.6%
1.2%
25
EBioMedicine
39 papers in training set
Top 0.7%
1.0%
26
Genome Medicine
154 papers in training set
Top 6%
1.0%
27
Neoplasia
22 papers in training set
Top 0.4%
1.0%
28
Pharmaceuticals
33 papers in training set
Top 1%
0.8%
29
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.8%
30
Molecular Cancer
14 papers in training set
Top 0.8%
0.8%